Delivery Order SPE2DX15D1907-SPE2DX24FD2LS

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $3.4K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,377.50 Firm Fixed Price delivery order is for the supply of GLYCOPYRROLATE INJECT, a medication used to treat certain conditions. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen, through its Corporate Office division, is the prime contractor and there is no set-aside designation. This award...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,910.85 firm fixed-price contract is for the supply of GLYCOPYRROLATE 0.2 MG/ML medication, a critical pharmaceutical product used in medical treatment. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,252.97 firm-fixed-price delivery order is for the supply of GLYCOPYRROLATE INJECT, a pharmaceutical product, with a completion date of August 9, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans' hospitals....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,109.89 firm fixed-price delivery order is for the supply of GLYCOPYRROLATE 0.2 MG/ML VIALML, a medication. The contract has an ultimate completion date of May 9, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of glycopyrrolate 0.2 mg/ml vial, 2 ml, a medication used to treat certain medical conditions. The contract has a ceiling value of $4,591.37 and a completion date of July 22, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a...
This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,341.26, is for the supply of glycopyrrolate 0.2 mg/ml vials (20 ml) to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of May 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,408.53, is for the supply of Glycopyrrolate 25S, a medication used for various medical purposes. The contract has a firm fixed price pricing type and an ultimate completion date of September 5, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GLYCOPYRROLATE INJECT, a pharmaceutical product. The contract is a delivery order with a firm fixed price of $1,255.95 and a period of performance through February 13, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is the prime contractor on an Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,157.14 firm fixed-price delivery order is for the supply of 4 mg/20 ml vials of the medication glycopyrrolate. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies supporting...
  • SPE2DX15D1907
    Indefinite Delivery Contract
  • SPE2DX15D1907-SPE2DX24FD2LS
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,442.46, is for the supply of GLYCOPYRROLATE INJECT, a medication, and is a firm fixed-price delivery order with an ultimate completion date of August 15, 2024. The contract has no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, for providing a broad range of pharmaceutical and medical supplies to support military treatment programs, veterans' healthcare, and other federal beneficiaries across the United States.

Generated 11/15/24, 9:22 AM